查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1857132

纖維蛋白原：全球市佔率排名、總銷售額與需求預測，2025-2031年

Fibrinogen - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
出版日期: | 出版商: QYResearch | 英文 100 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024年全球纖維蛋白原市場規模估計為12.57億美元，預計到2031年將達到25.25億美元，在2025-2031年的預測期內，年複合成長率為10.3%。

本報告對纖維蛋白原的跨境產業佈局、資本配置模式、區域經濟相互依存關係以及近期關稅調整和國際供應鏈重組戰略措施進行了全面評估。

纖維蛋白原（因子I）是一種脊椎動物糖蛋白，有助於血液凝固。纖維蛋白原濃縮物用於治療血液疾病。纖維蛋白原濃縮物是由混合血漿製備的凝血因子製劑。目前，只有RiaStap（CSL Behring）在許多國家獲得許可，可用於多種適應症，包括治療與低纖維蛋白原血症相關的急性出血。其他製造商的產品僅在其各自的地區或國家/地區銷售。

纖維蛋白原市場的主要驅動力是出血性疾病和需要快速止血的外科手術的日益增多，以及人們對標靶血液管理療法的認知和應用不斷提高。血漿分餾和重組技術的進步，以及對更安全、無病原體和高純度血液製品的需求不斷成長，也推動了市場成長。此外，人口老化、創傷和心血管手術發生率的上升，以及新興地區醫療基礎設施的持續改善，也促進了對纖維蛋白原濃縮物的需求成長。

全球主要的纖維蛋白原濃縮物生產商包括CSL Behring、LFB Group和Shanghai RAAS Blood Products。市場佔有率最大的公司約為52%。北美市場佔有率最大，約31%，其次是歐洲（約28%）和亞太地區（約26%）。

本報告目的是全面概述全球纖維蛋白原市場，重點關注總銷售量、收入、價格、市場佔有率和主要企業的排名，並依地區、國家、類型和應用進行分析。

本報告以銷售量（公斤）和銷售收入（百萬美元）為單位，提供纖維蛋白原市場規模、估算和預測資料，涵蓋2020年至2031年的歷史資料和預測資料，並以2024年為基準年。定量和定性分析將幫助讀者制定業務/成長策略、評估市場競爭格局、分析公司在當前市場中的地位，並就纖維蛋白原業務做出明智的決策。

目錄

第1章 市場概覽

  • 纖維蛋白原產品介紹
  • 全球纖維蛋白原市場規模預測
  • 纖維蛋白原市場趨勢及促進因素
  • 前提條件和限制條件
  • 調查目的
  • 考察年數

第2章 公司競爭分析

  • 全球纖維蛋白原公司營收排名（2024年）
  • 全球纖維蛋白原公司營收（2020-2025年）
  • 全球纖維蛋白原銷售量排名（2024年）
  • 全球纖維蛋白原銷售量（依公司）（2020-2025年）
  • 全球纖維蛋白原平均價格（依公司）（2020-2025年）
  • 主要製造商的纖維蛋白原生產基地和總部
  • 主要製造商的纖維蛋白原產品提供
  • 主要製造商的纖維蛋白原量産開始時期
  • 纖維蛋白原市場競爭分析
  • 併購、擴張

第3章 依類型細分

  • 依類型介紹
    • 人類纖維蛋白原
    • 動物纖維蛋白原
  • 全球纖維蛋白原銷售額（依類型）
  • 全球纖維蛋白原銷售量（依類型）
  • 全球纖維蛋白原平均價格（依類型）（2020-2031年）

第4章 依應用細分

  • 依應用介紹
    • 先天性纖維蛋白原缺乏症
    • 手術過程
    • 其他
  • 全球纖維蛋白原銷售額（依應用）
  • 全球纖維蛋白原銷售量（依應用）
  • 全球纖維蛋白原平均價格（依應用）（2020-2031年）

第5章 區域細分

  • 全球纖維蛋白原銷售額（依地區）
  • 全球纖維蛋白原銷售量（依地區）
  • 全球各地區纖維蛋白原平均價格（2020-2031年）
  • 北美洲
  • 歐洲
  • 亞太地區
  • 南美洲
  • 中東和非洲

第6章 依主要國家分類

  • 主要國家和地區纖維蛋白原銷售額成長趨勢（2020年、2024年和2031年比較）
  • 主要國家和地區的纖維蛋白原銷售額和銷售量
  • 美國
  • 歐洲
  • 中國
  • 日本
  • 韓國
  • 東南亞
  • 印度

第7章 公司簡介

  • CSL Behring
  • LFB Group
  • Shanghai RAAS Blood Products
  • China Resources Boya Bio-pharmaceutical
  • Hualan Biological Engineering
  • Harbin Pacific Biopharmaceutical
  • China Meheco Group
  • Taibang Biologic
  • Octapharma

第8章 產業鏈分析

第9章 研究結果與結論

第10章 附錄

The global market for Fibrinogen was estimated to be worth US$ 1257 million in 2024 and is forecast to a readjusted size of US$ 2525 million by 2031 with a CAGR of 10.3% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Fibrinogen cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer's products are justly used in local region or countries.

The market for fibrinogen is primarily driven by the increasing prevalence of bleeding disorders and surgical procedures that require rapid hemostasis, as well as growing awareness and adoption of targeted blood management therapies. Advances in plasma fractionation and recombinant technologies, along with rising demand for safer, pathogen-reduced, and high-purity blood products, are also fueling market growth. Additionally, an aging population, higher incidence of trauma and cardiovascular surgeries, and expansion of healthcare infrastructure in emerging regions contribute to the increasing demand for fibrinogen concentrate.

Global core fibrinogen manufacturers include CSL Behring, LFB Group and Shanghai RAAS Blood Products etc. The top 1 companies hold a share about 52%. North America is the largest market, with a share about 31%, followed by Europe and Asia Pacific with the share about 28% and 26%.

This report aims to provide a comprehensive presentation of the global market for Fibrinogen, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Fibrinogen by region & country, by Type, and by Application.

The Fibrinogen market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fibrinogen.

Market Segmentation

By Company

  • CSL Behring
  • LFB Group
  • Shanghai RAAS Blood Products
  • China Resources Boya Bio-pharmaceutical
  • Hualan Biological Engineering
  • Harbin Pacific Biopharmaceutical
  • China Meheco Group
  • Taibang Biologic
  • Octapharma

Segment by Type

  • Human Fibrinogen
  • Animal Fibrinogen

Segment by Application

  • Congenital Fibrinogen Deficiency
  • Surgical Procedures
  • Others

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Fibrinogen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Fibrinogen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Fibrinogen in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Fibrinogen Product Introduction
  • 1.2 Global Fibrinogen Market Size Forecast
    • 1.2.1 Global Fibrinogen Sales Value (2020-2031)
    • 1.2.2 Global Fibrinogen Sales Volume (2020-2031)
    • 1.2.3 Global Fibrinogen Sales Price (2020-2031)
  • 1.3 Fibrinogen Market Trends & Drivers
    • 1.3.1 Fibrinogen Industry Trends
    • 1.3.2 Fibrinogen Market Drivers & Opportunity
    • 1.3.3 Fibrinogen Market Challenges
    • 1.3.4 Fibrinogen Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Fibrinogen Players Revenue Ranking (2024)
  • 2.2 Global Fibrinogen Revenue by Company (2020-2025)
  • 2.3 Global Fibrinogen Players Sales Volume Ranking (2024)
  • 2.4 Global Fibrinogen Sales Volume by Company Players (2020-2025)
  • 2.5 Global Fibrinogen Average Price by Company (2020-2025)
  • 2.6 Key Manufacturers Fibrinogen Manufacturing Base and Headquarters
  • 2.7 Key Manufacturers Fibrinogen Product Offered
  • 2.8 Key Manufacturers Time to Begin Mass Production of Fibrinogen
  • 2.9 Fibrinogen Market Competitive Analysis
    • 2.9.1 Fibrinogen Market Concentration Rate (2020-2025)
    • 2.9.2 Global 5 and 10 Largest Manufacturers by Fibrinogen Revenue in 2024
    • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibrinogen as of 2024)
  • 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Human Fibrinogen
    • 3.1.2 Animal Fibrinogen
  • 3.2 Global Fibrinogen Sales Value by Type
    • 3.2.1 Global Fibrinogen Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Fibrinogen Sales Value, by Type (2020-2031)
    • 3.2.3 Global Fibrinogen Sales Value, by Type (%) (2020-2031)
  • 3.3 Global Fibrinogen Sales Volume by Type
    • 3.3.1 Global Fibrinogen Sales Volume by Type (2020 VS 2024 VS 2031)
    • 3.3.2 Global Fibrinogen Sales Volume, by Type (2020-2031)
    • 3.3.3 Global Fibrinogen Sales Volume, by Type (%) (2020-2031)
  • 3.4 Global Fibrinogen Average Price by Type (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Congenital Fibrinogen Deficiency
    • 4.1.2 Surgical Procedures
    • 4.1.3 Others
  • 4.2 Global Fibrinogen Sales Value by Application
    • 4.2.1 Global Fibrinogen Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Fibrinogen Sales Value, by Application (2020-2031)
    • 4.2.3 Global Fibrinogen Sales Value, by Application (%) (2020-2031)
  • 4.3 Global Fibrinogen Sales Volume by Application
    • 4.3.1 Global Fibrinogen Sales Volume by Application (2020 VS 2024 VS 2031)
    • 4.3.2 Global Fibrinogen Sales Volume, by Application (2020-2031)
    • 4.3.3 Global Fibrinogen Sales Volume, by Application (%) (2020-2031)
  • 4.4 Global Fibrinogen Average Price by Application (2020-2031)

5 Segmentation by Region

  • 5.1 Global Fibrinogen Sales Value by Region
    • 5.1.1 Global Fibrinogen Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Fibrinogen Sales Value by Region (2020-2025)
    • 5.1.3 Global Fibrinogen Sales Value by Region (2026-2031)
    • 5.1.4 Global Fibrinogen Sales Value by Region (%), (2020-2031)
  • 5.2 Global Fibrinogen Sales Volume by Region
    • 5.2.1 Global Fibrinogen Sales Volume by Region: 2020 VS 2024 VS 2031
    • 5.2.2 Global Fibrinogen Sales Volume by Region (2020-2025)
    • 5.2.3 Global Fibrinogen Sales Volume by Region (2026-2031)
    • 5.2.4 Global Fibrinogen Sales Volume by Region (%), (2020-2031)
  • 5.3 Global Fibrinogen Average Price by Region (2020-2031)
  • 5.4 North America
    • 5.4.1 North America Fibrinogen Sales Value, 2020-2031
    • 5.4.2 North America Fibrinogen Sales Value by Country (%), 2024 VS 2031
  • 5.5 Europe
    • 5.5.1 Europe Fibrinogen Sales Value, 2020-2031
    • 5.5.2 Europe Fibrinogen Sales Value by Country (%), 2024 VS 2031
  • 5.6 Asia Pacific
    • 5.6.1 Asia Pacific Fibrinogen Sales Value, 2020-2031
    • 5.6.2 Asia Pacific Fibrinogen Sales Value by Region (%), 2024 VS 2031
  • 5.7 South America
    • 5.7.1 South America Fibrinogen Sales Value, 2020-2031
    • 5.7.2 South America Fibrinogen Sales Value by Country (%), 2024 VS 2031
  • 5.8 Middle East & Africa
    • 5.8.1 Middle East & Africa Fibrinogen Sales Value, 2020-2031
    • 5.8.2 Middle East & Africa Fibrinogen Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Fibrinogen Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Fibrinogen Sales Value and Sales Volume
    • 6.2.1 Key Countries/Regions Fibrinogen Sales Value, 2020-2031
    • 6.2.2 Key Countries/Regions Fibrinogen Sales Volume, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Fibrinogen Sales Value, 2020-2031
    • 6.3.2 United States Fibrinogen Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Fibrinogen Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Fibrinogen Sales Value, 2020-2031
    • 6.4.2 Europe Fibrinogen Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Fibrinogen Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Fibrinogen Sales Value, 2020-2031
    • 6.5.2 China Fibrinogen Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Fibrinogen Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Fibrinogen Sales Value, 2020-2031
    • 6.6.2 Japan Fibrinogen Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Fibrinogen Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Fibrinogen Sales Value, 2020-2031
    • 6.7.2 South Korea Fibrinogen Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Fibrinogen Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Fibrinogen Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Fibrinogen Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Fibrinogen Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Fibrinogen Sales Value, 2020-2031
    • 6.9.2 India Fibrinogen Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Fibrinogen Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 CSL Behring
    • 7.1.1 CSL Behring Company Information
    • 7.1.2 CSL Behring Introduction and Business Overview
    • 7.1.3 CSL Behring Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.1.4 CSL Behring Fibrinogen Product Offerings
    • 7.1.5 CSL Behring Recent Development
  • 7.2 LFB Group
    • 7.2.1 LFB Group Company Information
    • 7.2.2 LFB Group Introduction and Business Overview
    • 7.2.3 LFB Group Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.2.4 LFB Group Fibrinogen Product Offerings
    • 7.2.5 LFB Group Recent Development
  • 7.3 Shanghai RAAS Blood Products
    • 7.3.1 Shanghai RAAS Blood Products Company Information
    • 7.3.2 Shanghai RAAS Blood Products Introduction and Business Overview
    • 7.3.3 Shanghai RAAS Blood Products Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.3.4 Shanghai RAAS Blood Products Fibrinogen Product Offerings
    • 7.3.5 Shanghai RAAS Blood Products Recent Development
  • 7.4 China Resources Boya Bio-pharmaceutical
    • 7.4.1 China Resources Boya Bio-pharmaceutical Company Information
    • 7.4.2 China Resources Boya Bio-pharmaceutical Introduction and Business Overview
    • 7.4.3 China Resources Boya Bio-pharmaceutical Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.4.4 China Resources Boya Bio-pharmaceutical Fibrinogen Product Offerings
    • 7.4.5 China Resources Boya Bio-pharmaceutical Recent Development
  • 7.5 Hualan Biological Engineering
    • 7.5.1 Hualan Biological Engineering Company Information
    • 7.5.2 Hualan Biological Engineering Introduction and Business Overview
    • 7.5.3 Hualan Biological Engineering Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.5.4 Hualan Biological Engineering Fibrinogen Product Offerings
    • 7.5.5 Hualan Biological Engineering Recent Development
  • 7.6 Harbin Pacific Biopharmaceutical
    • 7.6.1 Harbin Pacific Biopharmaceutical Company Information
    • 7.6.2 Harbin Pacific Biopharmaceutical Introduction and Business Overview
    • 7.6.3 Harbin Pacific Biopharmaceutical Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.6.4 Harbin Pacific Biopharmaceutical Fibrinogen Product Offerings
    • 7.6.5 Harbin Pacific Biopharmaceutical Recent Development
  • 7.7 China Meheco Group
    • 7.7.1 China Meheco Group Company Information
    • 7.7.2 China Meheco Group Introduction and Business Overview
    • 7.7.3 China Meheco Group Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.7.4 China Meheco Group Fibrinogen Product Offerings
    • 7.7.5 China Meheco Group Recent Development
  • 7.8 Taibang Biologic
    • 7.8.1 Taibang Biologic Company Information
    • 7.8.2 Taibang Biologic Introduction and Business Overview
    • 7.8.3 Taibang Biologic Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.8.4 Taibang Biologic Fibrinogen Product Offerings
    • 7.8.5 Taibang Biologic Recent Development
  • 7.9 Octapharma
    • 7.9.1 Octapharma Company Information
    • 7.9.2 Octapharma Introduction and Business Overview
    • 7.9.3 Octapharma Fibrinogen Sales, Revenue, Price and Gross Margin (2020-2025)
    • 7.9.4 Octapharma Fibrinogen Product Offerings
    • 7.9.5 Octapharma Recent Development

8 Industry Chain Analysis

  • 8.1 Fibrinogen Industrial Chain
  • 8.2 Fibrinogen Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Fibrinogen Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Fibrinogen Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer

List of Tables

  • Table 1. Fibrinogen Market Trends
  • Table 2. Fibrinogen Market Drivers & Opportunity
  • Table 3. Fibrinogen Market Challenges
  • Table 4. Fibrinogen Market Restraints
  • Table 5. Global Fibrinogen Revenue by Company (2020-2025) & (US$ Million)
  • Table 6. Global Fibrinogen Revenue Market Share by Company (2020-2025)
  • Table 7. Global Fibrinogen Sales Volume by Company (2020-2025) & (Kg)
  • Table 8. Global Fibrinogen Sales Volume Market Share by Company (2020-2025)
  • Table 9. Global Market Fibrinogen Price by Company (2020-2025) & (US$/g)
  • Table 10. Key Manufacturers Fibrinogen Manufacturing Base and Headquarters
  • Table 11. Key Manufacturers Fibrinogen Product Type
  • Table 12. Key Manufacturers Time to Begin Mass Production of Fibrinogen
  • Table 13. Global Fibrinogen Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibrinogen as of 2024)
  • Table 15. Mergers & Acquisitions, Expansion Plans
  • Table 16. Global Fibrinogen Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 17. Global Fibrinogen Sales Value by Type (2020-2025) & (US$ Million)
  • Table 18. Global Fibrinogen Sales Value by Type (2026-2031) & (US$ Million)
  • Table 19. Global Fibrinogen Sales Market Share in Value by Type (2020-2025)
  • Table 20. Global Fibrinogen Sales Market Share in Value by Type (2026-2031)
  • Table 21. Global Fibrinogen Sales Volume by Type: 2020 VS 2024 VS 2031 (Kg)
  • Table 22. Global Fibrinogen Sales Volume by Type (2020-2025) & (Kg)
  • Table 23. Global Fibrinogen Sales Volume by Type (2026-2031) & (Kg)
  • Table 24. Global Fibrinogen Sales Market Share in Volume by Type (2020-2025)
  • Table 25. Global Fibrinogen Sales Market Share in Volume by Type (2026-2031)
  • Table 26. Global Fibrinogen Price by Type (2020-2025) & (US$/g)
  • Table 27. Global Fibrinogen Price by Type (2026-2031) & (US$/g)
  • Table 28. Global Fibrinogen Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
  • Table 29. Global Fibrinogen Sales Value by Application (2020-2025) & (US$ Million)
  • Table 30. Global Fibrinogen Sales Value by Application (2026-2031) & (US$ Million)
  • Table 31. Global Fibrinogen Sales Market Share in Value by Application (2020-2025)
  • Table 32. Global Fibrinogen Sales Market Share in Value by Application (2026-2031)
  • Table 33. Global Fibrinogen Sales Volume by Application: 2020 VS 2024 VS 2031 (Kg)
  • Table 34. Global Fibrinogen Sales Volume by Application (2020-2025) & (Kg)
  • Table 35. Global Fibrinogen Sales Volume by Application (2026-2031) & (Kg)
  • Table 36. Global Fibrinogen Sales Market Share in Volume by Application (2020-2025)
  • Table 37. Global Fibrinogen Sales Market Share in Volume by Application (2026-2031)
  • Table 38. Global Fibrinogen Price by Application (2020-2025) & (US$/g)
  • Table 39. Global Fibrinogen Price by Application (2026-2031) & (US$/g)
  • Table 40. Global Fibrinogen Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
  • Table 41. Global Fibrinogen Sales Value by Region (2020-2025) & (US$ Million)
  • Table 42. Global Fibrinogen Sales Value by Region (2026-2031) & (US$ Million)
  • Table 43. Global Fibrinogen Sales Value by Region (2020-2025) & (%)
  • Table 44. Global Fibrinogen Sales Value by Region (2026-2031) & (%)
  • Table 45. Global Fibrinogen Sales Volume by Region (Kg): 2020 VS 2024 VS 2031
  • Table 46. Global Fibrinogen Sales Volume by Region (2020-2025) & (Kg)
  • Table 47. Global Fibrinogen Sales Volume by Region (2026-2031) & (Kg)
  • Table 48. Global Fibrinogen Sales Volume by Region (2020-2025) & (%)
  • Table 49. Global Fibrinogen Sales Volume by Region (2026-2031) & (%)
  • Table 50. Global Fibrinogen Average Price by Region (2020-2025) & (US$/g)
  • Table 51. Global Fibrinogen Average Price by Region (2026-2031) & (US$/g)
  • Table 52. Key Countries/Regions Fibrinogen Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
  • Table 53. Key Countries/Regions Fibrinogen Sales Value, (2020-2025) & (US$ Million)
  • Table 54. Key Countries/Regions Fibrinogen Sales Value, (2026-2031) & (US$ Million)
  • Table 55. Key Countries/Regions Fibrinogen Sales Volume, (2020-2025) & (Kg)
  • Table 56. Key Countries/Regions Fibrinogen Sales Volume, (2026-2031) & (Kg)
  • Table 57. CSL Behring Company Information
  • Table 58. CSL Behring Introduction and Business Overview
  • Table 59. CSL Behring Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 60. CSL Behring Fibrinogen Product Offerings
  • Table 61. CSL Behring Recent Development
  • Table 62. LFB Group Company Information
  • Table 63. LFB Group Introduction and Business Overview
  • Table 64. LFB Group Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 65. LFB Group Fibrinogen Product Offerings
  • Table 66. LFB Group Recent Development
  • Table 67. Shanghai RAAS Blood Products Company Information
  • Table 68. Shanghai RAAS Blood Products Introduction and Business Overview
  • Table 69. Shanghai RAAS Blood Products Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 70. Shanghai RAAS Blood Products Fibrinogen Product Offerings
  • Table 71. Shanghai RAAS Blood Products Recent Development
  • Table 72. China Resources Boya Bio-pharmaceutical Company Information
  • Table 73. China Resources Boya Bio-pharmaceutical Introduction and Business Overview
  • Table 74. China Resources Boya Bio-pharmaceutical Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 75. China Resources Boya Bio-pharmaceutical Fibrinogen Product Offerings
  • Table 76. China Resources Boya Bio-pharmaceutical Recent Development
  • Table 77. Hualan Biological Engineering Company Information
  • Table 78. Hualan Biological Engineering Introduction and Business Overview
  • Table 79. Hualan Biological Engineering Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 80. Hualan Biological Engineering Fibrinogen Product Offerings
  • Table 81. Hualan Biological Engineering Recent Development
  • Table 82. Harbin Pacific Biopharmaceutical Company Information
  • Table 83. Harbin Pacific Biopharmaceutical Introduction and Business Overview
  • Table 84. Harbin Pacific Biopharmaceutical Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 85. Harbin Pacific Biopharmaceutical Fibrinogen Product Offerings
  • Table 86. Harbin Pacific Biopharmaceutical Recent Development
  • Table 87. China Meheco Group Company Information
  • Table 88. China Meheco Group Introduction and Business Overview
  • Table 89. China Meheco Group Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 90. China Meheco Group Fibrinogen Product Offerings
  • Table 91. China Meheco Group Recent Development
  • Table 92. Taibang Biologic Company Information
  • Table 93. Taibang Biologic Introduction and Business Overview
  • Table 94. Taibang Biologic Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 95. Taibang Biologic Fibrinogen Product Offerings
  • Table 96. Taibang Biologic Recent Development
  • Table 97. Octapharma Company Information
  • Table 98. Octapharma Introduction and Business Overview
  • Table 99. Octapharma Fibrinogen Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
  • Table 100. Octapharma Fibrinogen Product Offerings
  • Table 101. Octapharma Recent Development
  • Table 102. Key Raw Materials Lists
  • Table 103. Raw Materials Key Suppliers Lists
  • Table 104. Fibrinogen Downstream Customers
  • Table 105. Fibrinogen Distributors List
  • Table 106. Research Programs/Design for This Report
  • Table 107. Key Data Information from Secondary Sources
  • Table 108. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Fibrinogen Product Picture
  • Figure 2. Global Fibrinogen Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
  • Figure 3. Global Fibrinogen Sales Value (2020-2031) & (US$ Million)
  • Figure 4. Global Fibrinogen Sales Volume (2020-2031) & (Kg)
  • Figure 5. Global Fibrinogen Sales Price (2020-2031) & (US$/g)
  • Figure 6. Fibrinogen Report Years Considered
  • Figure 7. Global Fibrinogen Players Revenue Ranking (2024) & (US$ Million)
  • Figure 8. Global Fibrinogen Players Sales Volume Ranking (2024) & (Kg)
  • Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Fibrinogen Revenue in 2024
  • Figure 10. Fibrinogen Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
  • Figure 11. Human Fibrinogen Picture
  • Figure 12. Animal Fibrinogen Picture
  • Figure 13. Global Fibrinogen Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 14. Global Fibrinogen Sales Value Market Share by Type, 2024 & 2031
  • Figure 15. Global Fibrinogen Sales Volume by Type (2020 VS 2024 VS 2031) & (Kg)
  • Figure 16. Global Fibrinogen Sales Volume Market Share by Type, 2024 & 2031
  • Figure 17. Global Fibrinogen Price by Type (2020-2031) & (US$/g)
  • Figure 18. Product Picture of Congenital Fibrinogen Deficiency
  • Figure 19. Product Picture of Surgical Procedures
  • Figure 20. Product Picture of Others
  • Figure 21. Global Fibrinogen Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
  • Figure 22. Global Fibrinogen Sales Value Market Share by Application, 2024 & 2031
  • Figure 23. Global Fibrinogen Sales Volume by Application (2020 VS 2024 VS 2031) & (Kg)
  • Figure 24. Global Fibrinogen Sales Volume Market Share by Application, 2024 & 2031
  • Figure 25. Global Fibrinogen Price by Application (2020-2031) & (US$/g)
  • Figure 26. North America Fibrinogen Sales Value (2020-2031) & (US$ Million)
  • Figure 27. North America Fibrinogen Sales Value by Country (%), 2024 VS 2031
  • Figure 28. Europe Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 29. Europe Fibrinogen Sales Value by Country (%), 2024 VS 2031
  • Figure 30. Asia Pacific Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 31. Asia Pacific Fibrinogen Sales Value by Region (%), 2024 VS 2031
  • Figure 32. South America Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 33. South America Fibrinogen Sales Value by Country (%), 2024 VS 2031
  • Figure 34. Middle East & Africa Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 35. Middle East & Africa Fibrinogen Sales Value by Country (%), 2024 VS 2031
  • Figure 36. Key Countries/Regions Fibrinogen Sales Value (%), (2020-2031)
  • Figure 37. Key Countries/Regions Fibrinogen Sales Volume (%), (2020-2031)
  • Figure 38. United States Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 39. United States Fibrinogen Sales Value by Type (%), 2024 VS 2031
  • Figure 40. United States Fibrinogen Sales Value by Application (%), 2024 VS 2031
  • Figure 41. Europe Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 42. Europe Fibrinogen Sales Value by Type (%), 2024 VS 2031
  • Figure 43. Europe Fibrinogen Sales Value by Application (%), 2024 VS 2031
  • Figure 44. China Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 45. China Fibrinogen Sales Value by Type (%), 2024 VS 2031
  • Figure 46. China Fibrinogen Sales Value by Application (%), 2024 VS 2031
  • Figure 47. Japan Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 48. Japan Fibrinogen Sales Value by Type (%), 2024 VS 2031
  • Figure 49. Japan Fibrinogen Sales Value by Application (%), 2024 VS 2031
  • Figure 50. South Korea Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 51. South Korea Fibrinogen Sales Value by Type (%), 2024 VS 2031
  • Figure 52. South Korea Fibrinogen Sales Value by Application (%), 2024 VS 2031
  • Figure 53. Southeast Asia Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 54. Southeast Asia Fibrinogen Sales Value by Type (%), 2024 VS 2031
  • Figure 55. Southeast Asia Fibrinogen Sales Value by Application (%), 2024 VS 2031
  • Figure 56. India Fibrinogen Sales Value, (2020-2031) & (US$ Million)
  • Figure 57. India Fibrinogen Sales Value by Type (%), 2024 VS 2031
  • Figure 58. India Fibrinogen Sales Value by Application (%), 2024 VS 2031
  • Figure 59. Fibrinogen Industrial Chain
  • Figure 60. Fibrinogen Manufacturing Cost Structure
  • Figure 61. Channels of Distribution (Direct Sales, and Distribution)
  • Figure 62. Bottom-up and Top-down Approaches for This Report
  • Figure 63. Data Triangulation
  • Figure 64. Key Executives Interviewed